Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
KLHL4
is a member of the KLHL protein family, many of whom bind the Cul3 E3 ligase, and mediate the ubiquitination of interacting proteins. The
KLHL4
gene, localized on the X chromosome, associates with a disorder known as X-linked cleft palate (CPX). However, the biological functions of
KLHL4
are largely unknown. In this study, microarray analysis of HEK293A embryonic kidney cells, expressing ectopic
p53
, showed a 3-fold increase of
KLHL4
mRNA. Moreover, both
KLHL4
mRNA and protein expression were elevated by
p53
or DNA damage, suggesting that
KLHL4
might be a p53 target gene. We also found that
KLHL4
activates transcription of p21
WAF/CDKN1A
, a p53 target gene encoding a major negative regulator of the cell-cycle.
KLHL4
interacted with
p53
to increase its binding to
p53
response element of the p21
WAF/CDKN1A
gene, resulting in transcriptional upregulation. Furthermore, we observed that
KLHL4
can interact with the Cul3 ubiquitin ligase, to possibly play a role in ubiquitin-mediated proteasomal degradation, and Klhl4 knocked-out MEF mouse embryonic fibroblasts proliferated faster than WT MEF cells. These results suggest that
KLHL4
upregulation by
p53
may inhibit cell proliferation, by activating p21
WAF/CDKN1A
.
...
PMID:KLHL4, a novel p53 target gene, inhibits cell proliferation by activating p21
WAF/CDKN1A
. 3275 15